Surrozen Closes Second Private Placement Tranche, Net Proceeds $95.1M
Surrozen closed a $95.1M private placement, securing cash runway to 2029 to advance its ophthalmology pipeline, specifically the SZN-8141 DUET study.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed